Shree Ganesh Remedies Limited (BOM:540737)
India
· Delayed Price · Currency is INR | Market Cap | 9.62B |
| Revenue (ttm) | 1.22B |
| Net Income (ttm) | 284.69M |
| Shares Out | 12.84M |
| EPS (ttm) | 22.19 |
| PE Ratio | 33.77 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,028 |
| Average Volume | 6,062 |
| Open | 701.00 |
| Previous Close | 714.30 |
| Day's Range | 697.85 - 745.00 |
| 52-Week Range | 557.95 - 950.05 |
| Beta | 0.42 |
| RSI | 54.67 |
| Earnings Date | May 30, 2025 |
About Shree Ganesh Remedies
Shree Ganesh Remedies Limited engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India. It provides anti-arrhythmic, anti-cancer, anti-depressant, anti-diabetic, anti-diarrheal, anti-fungal, anti-histamine, anti-inflammatory, anti-parasitic, anti-psychotic, anticholinergic, birth-control, cardiovascular, gastrointestinal, neurological disorder, ophthalmic, opioid, and veterinary API intermediates. The company also offers fine and specialty chemicals, such as ... [Read more]
Financial Performance
In 2023, Shree Ganesh Remedies's revenue was 1.26 billion, an increase of 39.54% compared to the previous year's 902.20 million. Earnings were 281.08 million, an increase of 65.14%.
Financial StatementsNews
Shree Ganesh Remedies commissions 2.5 MW solar power project, expects Rs 2 crore annual savings
Shree Ganesh Remedies Limited has announced the successful commissioning of a 2.5 MW solar power project, equipped with auto-tracker modules, on March 25, 2025. This project is expected to yield annua...